Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
BMC Medical Research Methodology|April 19, 2015
Validation of death prediction after breast cancer relapses using joint modelsAudrey Mauguen, Bernard Rachet, Simone Mathoulin-Pélissier, et al.
Annales De Pathologie|March 13, 2010
[Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]Florence Defaud-Hénon, Christine Tunon-de-Lara, Marion Fournier, et al.
American Journal of Surgery|May 13, 2014
Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision makingMarc Debled, Gaël Auxepaules, Christine Tunon de Lara, et al.
Scientific Reports|March 20, 2021
Terahertz refractive index-based morphological dilation for breast carcinoma delineationQuentin Cassar, Samuel Caravera, Gaëtan MacGrogan, et al.
Virchows Archiv : an International Journal of Pathology|June 7, 2007
Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-upIsabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, et al.
Bulletin Du Cancer|September 24, 2011
[Accuracy of intraoperative imprint cytology of sentinel lymph nodes in cT1 infiltrating breast cancer]Emilie Faller, Christine Tunon de Lara, Marion Fournier, et al.
Histopathology|October 15, 2013
Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative studyCamille Franchet, Thomas Filleron, Anne Cayre, et al.
Cancer|June 22, 2010
Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?Florence Ragage, Marc Debled, Gaëtan MacGrogan, et al.
Histopathology|August 17, 2021
Breast hamartoma: reassessment of an under-recognised breast lesionLéonie Alran, Foucauld Chamming's, Sophie Auriol-Leizagoyen, et al.
The American Journal of Surgical Pathology|January 11, 2019
SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung AdenocarcinomaElodie Laurent, Hugues Begueret, Benjamin Bonhomme, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
BMC Medical Research Methodology|April 19, 2015
Validation of death prediction after breast cancer relapses using joint modelsAudrey Mauguen, Bernard Rachet, Simone Mathoulin-Pélissier, et al.
Annales De Pathologie|March 13, 2010
[Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]Florence Defaud-Hénon, Christine Tunon-de-Lara, Marion Fournier, et al.
American Journal of Surgery|May 13, 2014
Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision makingMarc Debled, Gaël Auxepaules, Christine Tunon de Lara, et al.
Scientific Reports|March 20, 2021
Terahertz refractive index-based morphological dilation for breast carcinoma delineationQuentin Cassar, Samuel Caravera, Gaëtan MacGrogan, et al.
Virchows Archiv : an International Journal of Pathology|June 7, 2007
Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-upIsabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, et al.
Bulletin Du Cancer|September 24, 2011
[Accuracy of intraoperative imprint cytology of sentinel lymph nodes in cT1 infiltrating breast cancer]Emilie Faller, Christine Tunon de Lara, Marion Fournier, et al.
Histopathology|October 15, 2013
Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative studyCamille Franchet, Thomas Filleron, Anne Cayre, et al.
Cancer|June 22, 2010
Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?Florence Ragage, Marc Debled, Gaëtan MacGrogan, et al.
Histopathology|August 17, 2021
Breast hamartoma: reassessment of an under-recognised breast lesionLéonie Alran, Foucauld Chamming's, Sophie Auriol-Leizagoyen, et al.
The American Journal of Surgical Pathology|January 11, 2019
SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung AdenocarcinomaElodie Laurent, Hugues Begueret, Benjamin Bonhomme, et al.
Pageof 8